Britain's Simon Yates wins Tour de France 10th stage
The Giro d'Italia champion beat Thymen Arensman of the Netherlands and Ireland's Ben Healy, who finished second and third, respectively.
(Writing by Julien Pretot; Editing by Christian Radnedge)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNA
2 hours ago
- CNA
Bastianini and Espargaro to race for KTM Tech3 in Brno
Enea Bastianini will race for KTM Tech3 at this weekend's Czech Grand Prix after recovering from illness and Pol Espargaro steps in for the injured Maverick Vinales, the MotoGP team said on Wednesday. The 27-year-old Italian, who joined Tech3 from Ducati last year, missed the German Grand Prix but is expected to return to the track on Friday in practice for Sunday's race in Brno. "It was really tough for me to remain in bed for so long and unable to join the team at the German Grand Prix, but I gave myself the time to recover properly in order to arrive in Brno in good shape," Bastianini said in a statement. Spaniard Vinales had surgery on Sunday for a fractured left shoulder, paving the way for compatriot Espargaro to make his return with Tech3, a team he debuted with in MotoGP back in 2014. "It's been a long time since our last visit to Brno, which is a fantastic track," Espargaro said.
CNA
5 hours ago
- CNA
Apollo in talks to take stake in Atletico Madrid, report says
MADRID :U.S.-based buyout fund Apollo Global Management is in talks with the owner of Atletico Madrid to take a significant stake in the Spanish top-flight side, Expansion newspaper reported on Wednesday. The deal would value the team at roughly 2.5 billion euros ($2.91 billion) including debt, the report said, citing unidentified sources. The U.S. firm would get its stake via a capital increase of Atletico Holdco, which owns the majority of the club, it added. Atletico and Apollo did not immediately reply to requests for comment. ($1 = 0.8606 euros)
CNA
17 hours ago
- CNA
Britain's Moore handed four-year ban after CAS upholds ITIA appeal
Britain's Tara Moore, who was previously cleared of an anti-doping rule violation, was handed a four-year ban on Tuesday after the Court of Arbitration for Sport upheld an appeal filed by the International Tennis Integrity Agency. Moore, Britain's former number one-ranked doubles player, was provisionally suspended in June 2022 due to the presence of prohibited anabolic steroids Nandrolone and boldenone. Moore said she had never knowingly taken a banned substance in her career and an independent tribunal determined that contaminated meat consumed by her in the days before sample collection was the source of the prohibited substance. Moore lost 19 months in the process before she was cleared of the ADRV but CAS upheld the ITIA's appeal against the first instance "No Fault or Negligence" ruling with respect to nandrolone. "After reviewing the scientific and legal evidence, the majority of the CAS Panel considered that the player did not succeed in proving that the concentration of nandrolone in her sample was consistent with the ingestion of contaminated meat," CAS said in a statement. "The panel concluded that Ms Moore failed to establish that the ADRV was not intentional. The appeal by the ITIA is therefore upheld and the decision rendered by the Independent Tribunal is set aside." Moore had previously said how she saw her reputation, ranking and livelihood "slowly trickling away" for 19 months during her initial suspension. The 32-year-old had also filed a cross-appeal at CAS "seeking to dismiss the ITIA appeal, dismiss the nandrolone result in the ADRV or alternatively confirm that she bears no fault or negligence". However, CAS said the cross-appeal was declared inadmissible and her four-year period of ineligibility would start from July 15, with credit for any provisional suspension that has already been served. "Our bar for appealing a first instance decision is high, and the decision is not taken lightly," ITIA CEO Karen Moorhouse said in a statement. "In this case, our independent scientific advice was that the player did not adequately explain the high level of nandrolone present in their sample. Today's ruling is consistent with this position."
